NCT03846401

Brief Summary

Evaluate the diagnostic and therapeutic role of fiberoptic bronchoscopy in management of patients with lower respiratory tract infection in Respiratory Intensive Care Unit of Assiut University Hospital

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started May 2021

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 8, 2019

Completed
11 days until next milestone

First Posted

Study publicly available on registry

February 19, 2019

Completed
2.2 years until next milestone

Study Start

First participant enrolled

May 1, 2021

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2022

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2023

Completed
Last Updated

May 11, 2020

Status Verified

May 1, 2020

Enrollment Period

1 year

First QC Date

February 8, 2019

Last Update Submit

May 7, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Antimicrobial resistance pattern

    isolated organism and drug sensitivity test by Automated Vitek2 Compact(BioMérieux, France).

    1 year

Secondary Outcomes (2)

  • pathogen identification

    1 year

  • recovering an array of microorganisms

    1 year

Interventions

Will be performed according to British Thoracic Society guidelines 2013. -Microbiological methods The specimen (tracheal aspirate \& BAL) will be collected under aseptic conditions in a sterile container and immediately sent to the laboratory for microbiological analyses. Samples will be apply for: 1. Direct smear by Gram stain and ZeihlNelseen stain 2. Samples culturedinBact/alert bottle(BioMérieux, France). 3. Isolation of causative organism from positive cases by: Subculture on MacConkey , blood , chocolate agar , Sabouroud's agar and Lowenstien Jensen media. 4. Identification of isolated organism and drug sensitivity test by Automated Vitek2 Compact(BioMérieux, France). 5. Multiplex PCR for detection of Respiratory viruses in lower respiratory tract

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

patients with lower respiratory tract infection in the Respiratory Intensive Care Unit (R.I.C.U.), Department of Chest Diseases and Tuberculosis, Assiut University Hospital

You may qualify if:

  • Adult patients \> 18 years old in R.I.C.U who are on mechanical ventilator or high flow nasal cannula oxygen with lower respiratory tract infection or who show atelectasis on CXR in which the standard therapy failed will be included in this study

You may not qualify if:

  • Severely hypoxemic patients under high-FiO2 support and/or high PEEP, if the patient is unable to keep oxygen saturation \>90% with an FiO2 of 0.9-1.0 or a PaO2/FiO2 ratio of \<100, Severe acidosis, Ph\<7,2
  • Presence of pneumothorax
  • Active bronchospasm.
  • Patients with acute coronary problems, such as acute arrhythmia, acute myocardial infarction or ongoing hemodynamic instability, under vasoactive therapy.
  • patients with known intracranial hypertension
  • patients have coagulation abnormalities, such as thrombocytopenia or elevated prothrombin time

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (6)

  • Mahendra M, Jayaraj BS, Lokesh KS, Chaya SK, Veerapaneni VV, Limaye S, Dhar R, Swarnakar R, Ambalkar S, Mahesh PA. Antibiotic Prescription, Organisms and its Resistance Pattern in Patients Admitted to Respiratory ICU with Respiratory Infection in Mysuru. Indian J Crit Care Med. 2018 Apr;22(4):223-230. doi: 10.4103/ijccm.IJCCM_409_17.

    PMID: 29743760BACKGROUND
  • Ahmed SM, Jakribettu RP, Meletath SK, B A, Vpa S. Lower Respiratory Tract Infections (LTRIs): An Insight into the Prevalence and the Antibiogram of the Gram Negative, Respiratory, Bacterial Agents. J Clin Diagn Res. 2013 Feb;7(2):253-6. doi: 10.7860/JCDR/2013/5308.2740. Epub 2013 Jan 10.

    PMID: 23543819BACKGROUND
  • Jaffal K, Six S, Zerimech F, Nseir S. Relationship between hyperoxemia and ventilator associated pneumonia. Ann Transl Med. 2017 Nov;5(22):453. doi: 10.21037/atm.2017.10.15.

    PMID: 29264370BACKGROUND
  • Smeijsters KMG, Bijkerk RM, Daniels JMA, van de Ven PM, Girbes ARJ, Heunks LMA, Spijkstra JJ, Tuinman PR. Effect of Bronchoscopy on Gas Exchange and Respiratory Mechanics in Critically Ill Patients With Atelectasis: An Observational Cohort Study. Front Med (Lausanne). 2018 Nov 13;5:301. doi: 10.3389/fmed.2018.00301. eCollection 2018.

    PMID: 30483505BACKGROUND
  • Qiao Z, Yu J, Yu K, Zhang M. The benefit of daily sputum suction via bronchoscopy in patients of chronic obstructive pulmonary disease with ventilators: A randomized controlled trial. Medicine (Baltimore). 2018 Aug;97(31):e11631. doi: 10.1097/MD.0000000000011631.

    PMID: 30075543BACKGROUND
  • Chung SM, Choi JW, Lee YS, Choi JH, Oh JY, Min KH, Hur GY, Lee SY, Shim JJ, Kang KH. Clinical Effectiveness of High-Flow Nasal Cannula in Hypoxaemic Patients during Bronchoscopic Procedures. Tuberc Respir Dis (Seoul). 2019 Jan;82(1):81-85. doi: 10.4046/trd.2017.0104. Epub 2018 Jun 19.

    PMID: 29926544BACKGROUND

Study Officials

  • Maha K. Ghanem, Prof

    Assiut University

    STUDY CHAIR
  • Hoda A. Makhlouf, Prof

    Assiut University

    STUDY DIRECTOR
  • Ali A. Hasan, ass. prof.

    Assiut University

    STUDY DIRECTOR
  • Asmaa O. Ahmed, ass. prof

    Assiut University

    STUDY DIRECTOR

Central Study Contacts

Yara Y. Omar, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chest Specialist in Assiut University Hospital

Study Record Dates

First Submitted

February 8, 2019

First Posted

February 19, 2019

Study Start

May 1, 2021

Primary Completion

May 1, 2022

Study Completion

May 1, 2023

Last Updated

May 11, 2020

Record last verified: 2020-05